CIPROFLOXACIN tablet USA - engelsk - NLM (National Library of Medicine)

ciprofloxacin tablet

stat rx usa llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin hydrochloride 500 mg

CIPROFLOXACIN tablet USA - engelsk - NLM (National Library of Medicine)

ciprofloxacin tablet

aidarex pharmaceuticals llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 250 mg - ciprofloxacin tablets usp, 250 mg, 500 mg and 750 mg is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions and patient populations listed below. please see dosage and administration for specific recommendations. urinary tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, serratia marcescens, proteus mirabilis, providencia rettgeri, morganella morganii, citrobacter diversus, citrobacter freundii, pseudomonas aeruginosa, methicillin-susceptible staphylococcus epidermidis, staphylococcus saprophyticus, or enterococcus faecalis. acute uncomplicated cystitis in females caused by escherichia coli or staphylococcus saprophyticus. chronic bacterial prostatitis caused by escherichia coli or proteus mirabilis. lower respiratory tract infections caused by escherichia coli, klebsiella pneumoniae, enterobacter cloacae, proteus mirabilis, pseudomonas aeruginosa, haemophilus influenzae, ha

MEMANTINE HYDROCHLORIDE tablet, film coated USA - engelsk - NLM (National Library of Medicine)

memantine hydrochloride tablet, film coated

contract pharmacy services-pa - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 10 mg - memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the alzheimer's type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. pregnancy category b there are no adequate and well-controlled studies of memantine in pregnant women. memantine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. memantine given orally to pregnant rats and pregnant rabbits during the period of organogenesis was not teratogenic up to the highest doses tested (18 mg/kg/day in rats and 30 mg/kg/day in rabbits, which are 9 and 30 times, respectively, the maximum recommended human dose [mrhd] on a mg/m 2 basis). slight maternal toxicity, decreased pup weights and an increased incidence of non-ossified cervical vertebrae were seen at an oral dose of 18 mg/kg/day

MEMANTINE HYDROCHLORIDE solution USA - engelsk - NLM (National Library of Medicine)

memantine hydrochloride solution

macleods pharmaceuticals limited - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 2 mg in 1 ml - memantine hydrochloride solution is indicated for the treatment of moderate to severe dementia of the alzheimer's type. memantine hydrochloride solution is contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. teratogenic effects pregnancy category b there are no adequate and well-controlled studies of memantine in pregnant women. memantine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. memantine given orally to pregnant rats and pregnant rabbits during the period of organogenesis was not teratogenic up to the highest doses tested (18 mg/kg/day in rats and 30 mg/kg/day in rabbits, which are 9 and 30 times, respectively, the maximum recommended human dose [mrhd] on a mg/m 2 basis). slight maternal toxicity, decreased pup weights and an increased incidence of non-ossified cervical verte

Glucovance 500 mg/2,5 mg filmom obložene tablete Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

glucovance 500 mg/2,5 mg filmom obložene tablete

merck d.o.o., oreškovićeva ulica 6h/1, zagreb, hrvatska - metforminklorid glibenklamid - filmom obložena tableta - 500 mg + 2,5 mg - urbroj: svaka filmom obložena tableta sadržava 500 mg metforminklorida, što odgovara 390 mg metformina i 2,5 mg glibenklamida

Glucovance 500 mg/5 mg filmom obložene tablete Kroatia - kroatisk - HALMED (Agencija za lijekove i medicinske proizvode)

glucovance 500 mg/5 mg filmom obložene tablete

merck d.o.o., oreškovićeva ulica 6h/1, zagreb, hrvatska - metforminklorid, glibenklamid - filmom obložena tableta - 500 mg + 5 mg - urbroj: svaka filmom obložena tableta sadržava 500 mg metforminklorida, što odgovara 390 mg metformina i 5 mg glibenklamida

GLUCOVANCE 500MG/5MG FILM COATED TABLETS Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glucovance 500mg/5mg film coated tablets

merck a e hellas - Η ΥΔΡΟΧΛΩΡΙΚΉ ΜΕΤΦΟΡΜΊΝΗ ΓΛΙΒΕΝΚΛΑΜΊΔΗ - film coated tablets - 500mg/5mg - 0001115704 - metformin hydrochloride - 500 mg; 0010238218 - glibenclamide - 5 mg - metformin and sulfonamides

GLUCOVANCE 500MG/2.5MG FILM COATED TABLETS Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

glucovance 500mg/2.5mg film coated tablets

merck a e hellas - Η ΥΔΡΟΧΛΩΡΙΚΉ ΜΕΤΦΟΡΜΊΝΗ ΓΛΙΒΕΝΚΛΑΜΊΔΗ - film coated tablets - 500mg/2.5mg - 0001115704 - metformin hydrochloride - 500 mg; 0010238218 - glibenclamide - 2.5 mg - metformin and sulfonamides

Glucovance 2.5 mg + 500 mg Comprimido revestido por película Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

glucovance 2.5 mg + 500 mg comprimido revestido por película

merck, s.a. - glibenclamida + metformina - comprimido revestido por película - 2.5 mg + 500 mg - metformina, cloridrato 500 mg ; glibenclamida 2.5 mg - metformin and sulfonylureas - n/a - duração do tratamento: longa duração

Glucovance 2.5 mg + 500 mg Comprimido revestido por película Portugal - portugisisk - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

glucovance 2.5 mg + 500 mg comprimido revestido por película

merck, s.a. - glibenclamida + metformina - comprimido revestido por película - 2.5 mg + 500 mg - metformina, cloridrato 500 mg ; glibenclamida 2.5 mg - metformin and sulfonylureas - n/a - duração do tratamento: longa duração